巴洛沙星/1-环丙基-7-(3-甲氨基-1-哌啶基)-8-甲氧基-6-氟-1,4-二氢-4-氧代-3-喹啉羧酸

巴洛沙星/1-环丙基-7-(3-甲氨基-1-哌啶基)-8-甲氧基-6-氟-1,4-二氢-4-氧代-3-喹啉羧酸化学性质

安全信息

巴洛沙星/1-环丙基-7-(3-甲氨基-1-哌啶基)-8-甲氧基-6-氟-1,4-二氢-4-氧代-3-喹啉羧酸性质、用途与生产工艺

生物活性 Balofloxacin dehydrate (Q-35 dihydrate) 是一种具有口服活性的氟喹诺酮类抗生素，对革兰氏阴性，革兰氏阳性和厌氧菌具有广谱抗菌活性。Balofloxacin dehydrate 可用于研究呼吸道，肠道和泌尿道感染。
体外研究

Balofloxacin (25 mg/mL; 1 h) decreases the growth of S. aureus that adhered to human corneal epithelial cells (HCECs).
Balofloxacin inhibits the S. aureus ATCC 25923, with a MIC of 0.125 mg/mL.
Balofloxacin (0.05-500 μg/mL; 72 h) does not induce toxicity on the HCECs at a low concentration, such as 0.625 mg/mL.
体内研究

Balofloxacin (200 mg/kg/day; p.o. for 5 d) reduces the counts of viable M. pneumonia in the lungs of hamsters.
Balofloxacin eye drops (0.5%) is effective in S. aureus bacterial keratitis of rabbits.

巴洛沙星/1-环丙基-7-(3-甲氨基-1-哌啶基)-8-甲氧基-6-氟-1,4-二氢-4-氧代-3-喹啉羧酸上下游产品信息

上游原料

下游产品

巴洛沙星/1-环丙基-7-(3-甲氨基-1-哌啶基)-8-甲氧基-6-氟-1,4-二氢-4-氧代-3-喹啉羧酸生产厂家